AXP vs REPL · P/E 20, rev $41.30B vs $825.7M cap
American Express Company (AXP) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported AXP revenue for 2025-12-31 was $41.30B. Net income was $10.83B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
REPL does not have a complete income-statement cache yet.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. REPL currently screens at market cap $825.7M.
Not investment advice. Open the AXP and REPL stock pages for the full models.
Not investment advice.